Accelovance

Accelovance names Boccia oncology medical director

Friday, March 1, 2013 02:45 PM

Accelovance has named Dr. Ralph Boccia, M.D., FACP, oncology medical director.  The Rockville, Md.-based CRO caters to biotech and small/mid-sized pharma sponsors.

More... »


Accelovance names chief medical officer

Monday, November 14, 2011 02:33 PM

Accelovance has named Stephan A. Bart Sr., M.D. chief medical officer. Bart will be responsible for medical affairs and site operations, focused on enhancing the level of clinical solutions Accelovance can provide to clients.

More... »


Accelovance named "Best CRO"

Wednesday, April 20, 2011 11:33 AM

Accelovance, a privately held CRO, has been named the “Best Contract Research Organization (CRO)” for a third consecutive year. The World Vaccine Congress hosted its annual Vaccine Industry Excellence (ViE) Awards to honor and generate recognition of the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry over the past 12 months.

More... »

Accelovance gains industry recognition

Tuesday, March 1, 2011 08:11 AM

Rockville, Md.-based CRO Accelovance gained industry recognition in 2010 with a second consecutive “BEST CRO” ViE award.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs